Physician profile
Regine Mathew
NPI 1124793807
$688.56
in general payments reported to CMS, 2019-2025
13 companies · $513 in 2025
The $513 reported for 2025 was more than what 75% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $56.28 · 2024: $120 · 2025: $513.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $689.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $688.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $205.79 | 2025 | Interstim |
| Urogen Pharma, INC. | $124.97 | 2023-2025 | Jelmyto |
| Boston Scientific Corporation | $66.58 | 2023-2024 | Rezum Generator |
| Tolmar, INC. | $42.79 | 2024-2025 | Jatenzo, Eligard |
| Ambu INC. | $41.59 | 2025 | |
| Progenics Pharmaceuticals, INC. | $37.99 | 2025 | |
| Angiodynamics, INC. | $33.42 | 2024 | Nanoknife |
| Ethicon US, LLC | $28.49 | 2025 | Echelon Flex |
| Myriad Genetic Laboratories, INC. | $26.03 | 2025 | Myrisk |
| Janssen Biotech, INC. | $25.30 | 2025 | Erleada |
| Olympus America INC. | $22.44 | 2025 | Itind System |
| Convatec INC. | $20.19 | 2024 | |
| Laborie Medical Technologies Corp. | $12.98 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Regine Mathew listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.